Treatment Options for Breast Pain
For most women with breast pain, reassurance alone is sufficient—resolving symptoms in 86% with mild pain and 52% with severe pain—making it the most effective first-line intervention. 1
Initial Assessment and Risk Stratification
Before initiating treatment, determine the pain pattern and whether imaging is needed:
- Diffuse or cyclical breast pain: No imaging required regardless of age; proceed directly to symptomatic management 2, 1
- Focal, noncyclical breast pain in women <30 years: Ultrasound may be appropriate for reassurance 2, 1
- Focal, noncyclical breast pain in women 30-39 years: Mammography and ultrasound are equivalent options 2
- Focal, noncyclical breast pain in women ≥40 years: Mammography (with or without tomosynthesis) plus ultrasound 2
The cancer risk with breast pain alone is extremely low (0-3%), and imaging primarily serves to provide reassurance rather than detect malignancy 2, 1, 3
Stepwise Treatment Algorithm
First-Line: Conservative Non-Pharmacologic Measures
Start here for all patients with breast pain, as 85% will not require medication beyond reassurance: 4
- Reassurance: Explicitly inform patients that breast pain alone rarely indicates cancer 1, 5
- Well-fitted supportive bra: Proper breast support throughout the day 1, 5
- Topical comfort measures: Ice packs or heating pads as preferred 1, 5
- Over-the-counter analgesics: NSAIDs (ibuprofen, naproxen) or acetaminophen as needed 1, 5
- Regular physical exercise: May help reduce cyclical mastalgia 1
These conservative measures are effective for mild to moderate pain and should be trialed for at least 2-3 months before escalating therapy 5, 6
Second-Line: Topical NSAIDs
For persistent pain after conservative measures fail, topical NSAIDs are the preferred next step: 6
- Applied directly to the painful breast area
- Lower systemic side effects compared to oral medications
- Particularly useful for localized noncyclical pain 6
Third-Line: Pharmacologic Therapy (For Severe, Refractory Pain Only)
Reserve these medications for the 15% of patients with severe pain significantly impacting quality of life, as they carry substantial side effects: 4
Evidence-Based Pharmacologic Options:
- Only FDA-approved medication specifically for mastalgia
- Effective in 70-80% of patients with cyclical mastalgia
- Major limitation: Androgenic side effects (weight gain, acne, voice deepening, menstrual irregularities)
- Use lowest effective dose (100-200 mg daily) for shortest duration
- Effective for both cyclical and noncyclical mastalgia
- Lower doses (10 mg daily) often sufficient
- Major limitation: Hot flashes, increased thromboembolism risk, endometrial changes
- Requires careful patient selection and counseling
- Dopamine agonist that suppresses prolactin
- Effective primarily for cyclical mastalgia
- Major limitation: Nausea, dizziness, headache (often limits tolerability)
- Less commonly used due to side effect profile
Evening primrose oil (Gamolenic acid/EF-12) 4
- Historically used as first-line pharmacologic therapy
- Contains gamma-linolenic acid
- Evidence of efficacy is mixed; some studies show benefit for cyclical mastalgia 4
- Well-tolerated with minimal side effects
Treatment Success Rates
When using the stepwise approach with pharmacologic therapy reserved for severe cases: 4
- 92% of patients with cyclical mastalgia achieve clinically useful improvement
- 64% of patients with noncyclical mastalgia achieve clinically useful improvement
Special Considerations
Extramammary (Chest Wall) Pain
If breast examination and imaging are normal but pain persists, consider non-breast sources: 2
- Costochondritis (Tietze syndrome): Most common musculoskeletal cause 2
- Pectoral muscle strain or spasm 2
- Nerve entrapment: Lateral cutaneous branch of third intercostal nerve 2
Treatment for chest wall pain: 4
- Local injection of corticosteroid plus local anesthetic
- Oral NSAIDs
- Physical therapy for musculoskeletal causes
Duration of Treatment
- Most breast pain is self-limiting and resolves spontaneously within weeks to months 6
- For cyclical mastalgia, symptoms often improve after menopause 3
- Pharmacologic therapy should be time-limited (3-6 months) with reassessment 5
Critical Pitfalls to Avoid
Do not order mammography for routine breast pain in women <40 years: Exposes patients to unnecessary radiation without benefit (ACR rating 1/9 "usually not appropriate") 1, 7
Do not order MRI for breast pain evaluation: No evidence supports its use; leads to unnecessary biopsies of benign findings without improving cancer detection 1, 7
Do not aspirate small cysts found incidentally on ultrasound: These are unlikely to cause pain and aspiration provides no benefit 1, 7
Do not dismiss focal pain with a palpable finding based on negative imaging alone: Up to 10-15% of breast cancers can be mammographically occult; proceed to ultrasound and consider biopsy based on clinical judgment 8
Do not start pharmacologic therapy without adequate trial of conservative measures: The potentially serious adverse effects of hormonal medications (danazol, tamoxifen, bromocriptine) limit their use to selected patients with severe, sustained pain that impacts daily activities 3, 5
When to Reassess or Escalate
Return for re-evaluation if: 7
- Pain becomes persistently focal and noncyclical in a specific location
- A discrete palpable mass develops
- Associated symptoms emerge (bloody nipple discharge, skin dimpling, asymmetric thickening)
- Pain characteristics change significantly